Provider Groups File Appellate Briefs in Key 340B Contract Pharmacy Cases

Groups representing health centers, HIV/AIDS clinics, and hospitals filed briefs in key 340B contract pharmacy cases in federal appeals courts in Washington, D.C., and Philadelphia.

Groups representing health centers, HIV/AIDS clinics, and hospitals asked federal appeals courts in Philadelphia and Washington, D.C., this week to hold that drug manufacturers must give covered entities 340B discounts on drugs when entities use contract pharmacies to

Read More »

25 States Say Drug Companies’ 340B Contract Pharmacy Actions Are Illegal and Harm Public Health

An excerpt from one of the two friend of the court briefs that 25 states filed in pivotal 340B contract pharmacy litigation in federal appeals courts.

Drug manufacturers’ conditions on 340B pricing when covered entities use contract pharmacies violate federal law and ultimately diminish states’ public health efforts, 25 states told two federal appeals courts yesterday.

Please Login or Become

Read More »

News Alert

25 States File Joint Briefs Backing HHS and HRSA in 340B Contract Pharmacy Cases

Connecticut Attorney General William Tong (D) led the coalition of states backing the federal government in 340B contract pharmacy cases before federal appeals courts.

Twenty-five states are backing the federal government in litigation before two federal appeals courts over drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies.

Please Login or Become a Paid Subscriber

Read More »

Letting Pharma Put Strings on 340B is Letting Fox Guard Henhouse, Feds Tell Appeals Courts

The DOJ told federal appeals courts in Philadelphia and Washington, D.C., that HHS was right to tell drug manufacturers their conditions on 340B contract pharmacy are illegal and must end.

Letting drug manufacturers put conditions on 340B drug discounts “would be akin to letting the fox guard the henhouse,” the U.S. Justice Department (DOJ) told federal appeals courts in Philadelphia and Washington, D.C., last night in a pair

Read More »

Fed. Judge Lets 340B Providers Intervene in Closely Watched Contract Pharmacy Lawsuit

A federal judge is letting Piggott Community Hospital in northeastern Arkansas and Community Health Centers of Arkansas intervene in PhRMA's lawsuit challenging a state law protecting 340B contract pharmacy arrangements.

A federal district judge on Tuesday let Arkansas’ state health center association and a critical access hospital in the state have a role in the drug industry’s lawsuit challenging the state’s one-of-a-kind law protecting 340B contract pharmacy arrangements.

Read More »

California 340B Health Centers Blast CMS in Court Over its Role in State Medicaid Drug Benefit Transfer

California 340B health centers' suit against the state's transfer of Medicaid managed care drug benefits to Medicaid fee for service is being heard at the Robert T. Matsui United States Courthouse in Sacramento.

California health centers asked a federal district judge in late April to deny the U.S. Centers for Medicare & Medicaid Services (CMS) motion to dismiss the health centers’ claims against CMS arising over the state’s transfer of Medicaid

Read More »

Appeals Court Consolidates AstraZeneca, Sanofi, and Novo Nordisk’s 340B Contract Pharmacy Cases

The U.S. Third Circuit Court of Appeals has decided to hear and rule on AstraZeneca, Sanofi, and Novo Nordisk’s 340B contract pharmacy litigation together.

A federal appeals court in Philadelphia, as expected, has decided to consider and rule on AstraZeneca’s 340B contract pharmacy lawsuit in tandem with Sanofi and Novo Nordisk’s 340B contract pharmacy cases.

Please Login or

Read More »

At Direction of U.S. Appeals Court, Judge Issues Amended Judgement in Lilly’s 340B Contract Pharmacy Case

It is unknown whether U.S. Senior District Judge Sarah Evans Barker’s amended partial final judgement in Lilly's 340B contract pharmacy lawsuit will satisfy a higher court that kicked the case back to her.

A federal district judge in Indianapolis last week responded to a higher court’s directive and entered an amended partial final judgement in drug manufacturer Lilly’s 340B contract pharmacy lawsuit.

Please Login or Become a Paid Subscriber

Read More »

Feds Tell Court Tennessee Health System Paid for Referrals to Recoup “Staggering” 340B Discounts

The federal government told a court this week that Methodist Le Bonheur Healthcare agreed to pay a private oncology practice "for referrals and the opportunity to recoup discounts through the 340B program." Methodist has vowed to vigorously defend itself against what it says are meritless claims.

The federal government on Monday accused a Tennessee health system of unlawfully paying a Memphis-area private oncology practice for patient referrals, letting the system “recoup a staggering discount in costs” through the 340B program.

Please Login

Read More »
Generic selectors
Exact matches only
Search in title
Search in content